TQB2922 and TAS-102 Tablets for Injection With or Without Bevacizumab in Chemotherapy-failed RAS/BRAF Wild-type Advanced Colorectal Cancer

DRUG: TQB2922 injection ± TAS-102 tablets
DRUG: TQB2922 injection+TAS-102 tablets ± Bevacizumab

PHASE1,PHASE2

Phase

RECRUITING

Status

Enrollment

INDUSTRY

Sponsor class

Conditions

Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.